Xiao-bo Yang

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Efficacy and safety of transcatheter arterial chemoembolization combined with microwave ablation for hepatic hemangiomas (> 5 cm).

Efficacy and safety of transcatheter arterial chemoembolization combined with microwave ablation for hepatic hemangiomas (> 5 cm).

Journal: World journal of gastroenterology
Published: April 29, 2025

Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma.

Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma.

Journal: World journal of gastroenterology
Published: November 30, 2022

High incidence combination of multiple primary malignant tumors of the digestive system.

High incidence combination of multiple primary malignant tumors of the digestive system.

Journal: World journal of gastroenterology
Published: August 24, 2022

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.

Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.

Journal: World journal of gastroenterology
Published: August 19, 2022

Age, gender, geographic and clinical differences for gallstones in China: a nationwide study.

Age, gender, geographic and clinical differences for gallstones in China: a nationwide study.

Journal: Annals of translational medicine
Published: November 17, 2021

LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.

LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.

Journal: Aging
Published: September 22, 2020

Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma.

Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma
Published: August 10, 2020

Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.

Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.

Journal: World journal of gastroenterology
Published: July 20, 2020

Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.

Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.

Journal: International immunopharmacology
Published: July 06, 2020

Construction of a new immune-related signature based on three lncRNAs as the factor for prognosis prediction of hepatocellular carcinoma.

Construction of a new immune-related signature based on three lncRNAs as the factor for prognosis prediction of hepatocellular carcinoma.

Journal: Clinical and translational medicine
Published: June 12, 2020

Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.

Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.

Journal: Cancer medicine
Published: June 04, 2020

Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China.

Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China.

Journal: World journal of gastroenterology
Published: March 14, 2020
Showing 1-12 of 23

Last Updated: 09/26/2026